Mallinckrodt and MBI file PMA for FS069
Mallinckrodt Medical and Molecular Biosystems have filed a premarketapproval (PMA) application for cardiac uses of MBI's second-generationFS069 ultrasound contrast agent. The companies said the PMA coversclinical studies in which FS069 was used for
Mallinckrodt Medical and Molecular Biosystems have filed a premarketapproval (PMA) application for cardiac uses of MBI's second-generationFS069 ultrasound contrast agent. The companies said the PMA coversclinical studies in which FS069 was used for enhancing endocardialborder delineation, as well as opacification of the left ventricularchamber. Doppler signal enhancement was also studied.
San Diego-based MBI is developing FS069 and has granted licensingrights for the agent to Mallinckrodt of St. Louis for North andSouth America, China, Australia, and New Zealand (SCAN 9/13/95).Both parties are hoping the agent will prove more successful thanAlbunex, MBI's first-generation agent, which has received a tepidresponse from the ultrasound community since it was introducedin 1994. Mallinckrodt also markets Albunex.
A phase III clinical trial conducted for FS069's PMA comparedthe agent with Albunex, and demonstrated the newer agent's superiorityin providing endocardial border delineation as well as left ventricularcontrast enhancement, both of which improve visualization of cardiac-wallmotion and function.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
